The	O
role	O
of	O
p53	O
in	O
pigmentation	O
,	O
tanning	O
and	O
melanoma	B-Cancer
.	O

p53	O
has	O
a	O
central	O
role	O
in	O
skin	B-Organ
pigmentation	O
and	O
may	O
impact	O
on	O
melanoma	B-Cancer
at	O
all	O
stages	O
,	O
however	O
,	O
as	O
it	O
'	O
s	O
mutation	O
frequency	O
in	O
melanoma	B-Cancer
is	O
low	O
,	O
it	O
'	O
s	O
role	O
has	O
been	O
somewhat	O
under	O
-	O
appreciated	O
.	O

During	O
normal	O
skin	B-Organ
function	O
,	O
p53	O
in	O
the	O
keratinocyte	B-Cell
is	O
a	O
transducer	O
of	O
the	O
skin	B-Organ
tanning	O
signal	O
and	O
an	O
essential	O
component	O
of	O
what	O
is	O
effectively	O
a	O
keratinocyte	B-Cell
-	O
melanocyte	B-Cell
signaling	O
cycle	O
that	O
regulates	O
skin	B-Organ
pigmentation	O
.	O

It	O
is	O
clear	O
that	O
this	O
cycle	O
functions	O
optimally	O
in	O
skin	B-Organ
of	O
dark	O
pigmentation	O
.	O

When	O
melanin	O
biosynthesis	O
is	O
genetically	O
disrupted	O
in	O
skin	B-Organ
of	O
white	O
complexion	O
,	O
we	O
propose	O
that	O
this	O
cycle	O
operates	O
as	O
a	O
promoter	O
of	O
melanocyte	B-Cell
proliferation	O
.	O

The	O
cell	B-Cell
autonomous	O
function	O
of	O
p53	O
in	O
melanocytes	B-Cell
is	O
not	O
well	O
described	O
,	O
however	O
,	O
the	O
balance	O
of	O
the	O
evidence	O
suggests	O
that	O
p53	O
is	O
an	O
effective	O
tumor	B-Cancer
suppressor	O
and	O
the	O
myriad	O
of	O
mechanisms	O
by	O
which	O
the	O
p53	O
pathway	O
may	O
be	O
dysregulated	O
in	O
tumors	B-Cancer
attests	O
to	O
it	O
importance	O
as	O
a	O
tumor	B-Cancer
suppressor	O
.	O

In	O
this	O
review	O
,	O
we	O
outline	O
the	O
known	O
mechanisms	O
that	O
impair	O
p53	O
itself	O
and	O
its	O
immediate	O
regulators	O
or	O
target	O
genes	O
during	O
melanomagenesis	O
.	O

Due	O
to	O
the	O
importance	O
of	O
this	O
pathway	O
,	O
it	O
is	O
clear	O
that	O
p53	O
disruptions	O
may	O
relate	O
directly	O
to	O
a	O
patient	O
'	O
s	O
prognosis	O
.	O

This	O
pathway	O
will	O
continue	O
to	O
be	O
a	O
focus	O
of	O
investigation	O
,	O
particularly	O
with	O
respect	O
to	O
targeted	O
experimental	O
chemotherapeutics	O
.	O

